Back to search

University of British Columbia

Strategies to accelerate evidence generation and application in colorectal cancer care

Abstract

dc:description

Randomized control trials (RCTs) inform clinical practice recommendations for screening and the management of colorectal cancer (CRC), while also supporting regulatory decisions of novel therapies. However, RCTs require significant time investment that delays patient access to novel interventions. Strategies to expedite evidence generation are needed to improve RCT utility within clinical and regulatory frameworks. This thesis explored computerized simulations of CRC screening, self-directed and asynchronous electronic consenting (e-consenting) and surrogate endpoint use in RCTs as acceleratory strategies. First, OncoSim-CRC was used to support timely re-evaluation of national screening guidance due to rising rates of early-onset CRC by modelling the economic impacts of earlier screening. In a simulated cohort of 10 million Canadians with age-adjusted early-onset rates, earlier fecal immunochemical testing saved lives while increasing colonoscopy requirements 3.9–6.6%, while colonoscopy-first strategies also reduced mortality but increased colonoscopy requirements 89–116.7%. All strategies were cost-effective compared to current screening recommendations. Second, a self-directed e-consent was evaluated in a prospective oncology study to demonstrate patient acceptance of a new enrolment strategy aimed at improving recruitment. Fifty-one patients with cancer initially self-enrolled. After a follow-up call, 47 (92%) provided full consent and 41 (87%) did so asynchronously. Thirty-eight participants (93%) expressed comfortability enrolling without interacting with a research coordinator, suggesting strong acceptance of self-directed approaches. Third, a novel framework was developed to evaluate the validity of surrogate endpoints used to grant earlier access to promising therapies. A literature search was conducted, identifying 39 analyses of 12 surrogate endpoints used in CRC trials for framework evaluation. Framework-derived evidence scores were assigned based on seven domains of the surrogate relationship. Only disease-free survival was a strong surrogate for adjuvant trials (≥A18, median R² = 0.92). All endpoints in advanced-stage trials were unreliable, including progression-free survival (B6–A15, median R² = 0.55) and response rate (B6–A13, median R² = 0.33). These works advance the existing strategies that accelerate or complement RCT evidence. Microsimulations will support timely guideline revisions, asynchronous e-consent offers a novel enrolment strategy and the surrogate endpoint framework helps validate surrogates used for earlier clinical trial read out and gaining expedited regulatory approvals.

Degree

thesis:*
Name thesis:degree_name
Master of Science - MSc
Level thesis:degree_level
master's
Discipline thesis:degree_discipline
Experimental Medicine
Grantor dc:publisher
University of British Columbia
Year dc:date
2026

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Chia, Brendan Joshua
Contributors dc:contributor
  • Loree, Jonathan M.

Rights

dc:rights
Statement dc:rights
  • Attribution-NonCommercial-NoDerivatives 4.0 International
Language dc:language
eng

Identifiers

dc:identifier.*
Handle dc:identifier
http://hdl.handle.net/2429/94566

Chain of custody

source
Harvested from
University of British Columbia
Base URL
circle.library.ubc.ca/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Chia, Brendan Joshua. Strategies to accelerate evidence generation and application in colorectal cancer care. master's thesis, University of British Columbia, 2026. http://hdl.handle.net/2429/94566